The Claim
Activation of GLP-1 receptors leads to increased satiety, reduced appetite, and enhanced insulin secretion, which results in an average 15% reduction in body weight in humans treated with semaglutide.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When a drug like semaglutide turns on certain brain and body signals, it helps people feel fuller, eat less, and lose about 15% of their body weight on average.
See the scientific wording
Activation of GLP-1 receptors enhances satiety, suppresses appetite, and stimulates insulin secretion, resulting in an average 15% body weight reduction in humans treated with semaglutide.
What the research says
1 studyStudy: Once-Weekly Semaglutide in Adults with Overweight or Obesity.
The study tested semaglutide in people with obesity and found they lost almost 15% of their body weight on average, which matches the claim. The results support that the drug helps control appetite and leads to significant weight loss.
Related videos
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.